Zhang S - Search Results

1

STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.

Xu S, Yue Y, Zhang S, Zhou C, Cheng X, Xie X, Wang X, Lu W. Xu S, et al. Among authors: zhang s. J Exp Clin Cancer Res. 2018 Dec 5;37(1):305. doi: 10.1186/s13046-018-0977-y. J Exp Clin Cancer Res. 2018. PMID: 30518424 Free PMC article.

2

OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma.

Ye F, Zhang SF, Xie X, Lu WG. Ye F, et al. Cancer Invest. 2008 Jul;26(6):569-74. doi: 10.1080/07357900701837044. Cancer Invest. 2008. PMID: 18584347

3

TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer.

Zhang SF, Wang XY, Fu ZQ, Peng QH, Zhang JY, Ye F, Fu YF, Zhou CY, Lu WG, Cheng XD, Xie X. Zhang SF, et al. Autophagy. 2015;11(2):225-38. doi: 10.1080/15548627.2014.998931. Autophagy. 2015. PMID: 25607466 Free PMC article.

4

Autophagy maintains the stemness of ovarian cancer stem cells by FOXA2.

Peng Q, Qin J, Zhang Y, Cheng X, Wang X, Lu W, Xie X, Zhang S. Peng Q, et al. Among authors: zhang s, zhang y. J Exp Clin Cancer Res. 2017 Nov 29;36(1):171. doi: 10.1186/s13046-017-0644-8. J Exp Clin Cancer Res. 2017. PMID: 29187221 Free PMC article.

5

The inhibition of UBC13 expression and blockage of the DNMT1-CHFR-Aurora A pathway contribute to paclitaxel resistance in ovarian cancer.

Zhang X, Feng Y, Wang XY, Zhang YN, Yuan CN, Zhang SF, Shen YM, Fu YF, Zhou CY, Li X, Cheng XD, Lu WG, Xie X. Zhang X, et al. Cell Death Dis. 2018 Jan 24;9(2):93. doi: 10.1038/s41419-017-0137-x. Cell Death Dis. 2018. PMID: 29367628 Free PMC article.

6

High-Risk Human Papillomavirus E7 Maintains Stemness Via APH1B In Cervical Cancer Stem-Cell Like Cells.

Yang S, Chen T, Huang L, Xu S, Cao Z, Zhang S, Xu J, Li Y, Yue Y, Lu W, Cheng X, Xie X. Yang S, et al. Among authors: zhang s. Cancer Manag Res. 2019 Nov 12;11:9541-9552. doi: 10.2147/CMAR.S194239. eCollection 2019. Cancer Manag Res. 2019. PMID: 31814758 Free PMC article.

7

Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy.

Zhang S, Yan C, Millar DG, Yang Q, Heather JM, Langenbucher A, Morton LT, Sepulveda S, Alpert E, Whelton LR, Zarrella DT, Guo M, Minogue E, Lawrence MS, Rueda BR, Spriggs DR, Lu W, Langenau DM, Cobbold M. Zhang S, et al. Cancer Res. 2022 Mar 1;82(5):773-784. doi: 10.1158/0008-5472.CAN-21-2200. Cancer Res. 2022. PMID: 34965933

8

PLAA suppresses ovarian cancer metastasis via METTL3-mediated m⁶A modification of TRPC3 mRNA.

Shen Z, Gu L, Liu Y, Wang L, Zhu J, Tang S, Wei X, Wang J, Zhang S, Wang X, Cheng X, Xie X, Lu W. Shen Z, et al. Among authors: zhang s. Oncogene. 2022 Aug;41(35):4145-4158. doi: 10.1038/s41388-022-02411-w. Epub 2022 Jul 22. Oncogene. 2022. PMID: 35869392 Free PMC article.

9

PGAM1 Promotes Glycolytic Metabolism and Paclitaxel Resistance via Pyruvic Acid Production in Ovarian Cancer Cells.

Feng Y, Zhang X, Zhang S, Xu S, Chen X, Zhou C, Xi Y, Xie X, Lu W. Feng Y, et al. Among authors: zhang s, zhang x. Front Biosci (Landmark Ed). 2022 Sep 16;27(9):262. doi: 10.31083/j.fbl2709262. Front Biosci (Landmark Ed). 2022. PMID: 36224008 Free article.

10

Long non-coding RNA SLC25A21-AS1 inhibits the development of epithelial ovarian cancer by specifically inducing PTBP3 degradation.

Li S, Shen S, Ge W, Cen Y, Zhang S, Cheng X, Wang X, Xie X, Lu W. Li S, et al. Among authors: zhang s. Biomark Res. 2023 Jan 30;11(1):12. doi: 10.1186/s40364-022-00432-x. Biomark Res. 2023. PMID: 36717926 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78,966 results

Search Page